Loading news...
New York State Common Retirement Fund decreased its stake in RadNet, Inc. (NASDAQ: RDNT) by 5.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 247,479 shares of the medical research company's stock after selling 13,532 shares during the quarter.
/PRNewswire/ -- USANewsGroup.com News Commentary - The global medical imaging market hit a massive $45.5 billion in 2026[1], marking a total structural shift
Emerald Advisers LLC trimmed its position in RadNet, Inc. (NASDAQ: RDNT) by 4.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 642,167 shares of the medical research company's stock after selling 30,189 shares during the quarter. RadNet comprises 1.6% of Emerald
New York State Teachers Retirement System grew its holdings in RadNet, Inc. (NASDAQ: RDNT) by 53.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 30,855 shares of the medical research company's stock after acquiring an additional 10,700 shares during the
RadNet, Inc. (RDNT) Presents at 44th Annual J.P. Morgan Healthcare Conference Prepared Remarks Transcript
LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer, Dr. Gregory Sorensen, Executive Vice President and Chief Strategy Officer and Kees Wesdorp, President & CEO of RadNet Digital Health will be presenting at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 10:30 a.m. PST.
LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, announced today that it has acquired Radiology Regional, a division of LucidHealth serving Southwest Florida. The expansion brings RadNet's proven operational efficiencies and leading imaging technologies to 13 locations across Naples, Cape Coral, Fort Myers, Port Charlotte and Sarasota.
Texas Permanent School Fund Corp lessened its stake in shares of RadNet, Inc. (NASDAQ: RDNT) by 17.9% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,665 shares of the medical research company's stock after selling 8,887 shares during the
RadNet, Inc. (NASDAQ: RDNT) stock is trading lower on Tuesday. Hunterbrook Capital released a short report on Tuesday on the company, stating that the smaller companies are slapping "AI" on their pitch decks and watching their valuations soar.
Castleark Management LLC increased its stake in shares of RadNet, Inc. (NASDAQ: RDNT) by 241.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 96,203 shares of the medical research company's stock after buying an additional 68,050 shares
Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates, 1 risk stratification tools, and viewing and reporting workflow acceleration CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced today the launch of the DeepHealth Breast Suite, 2 a first-of-its-kind end-to-end suite of modular, interoperable AI-powered applications that address real-world clinical needs across the breast cancer screening and detection pathways. Breast Suite builds on organic innovation and integrated technologies from iCAD to deliver a comprehensive new suite of solutions.
CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today unveils an expanded portfolio at RSNA 2025, introducing next-generation imaging informatics and clinical AI solutions. The company is announcing new offerings and major enhancements across its portfolio, spanning disease detection, assessment and monitoring, remote scanning, image management and interpretation, center operations and AI orchestration—all designed to transform the imaging experience and advance population health.
Creative Planning raised its stake in shares of RadNet, Inc. (NASDAQ: RDNT) by 76.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 24,592 shares of the medical research company's stock after buying an additional 10,637 shares during the quarter. Creative Planning's
Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in RadNet, Inc. (NASDAQ: RDNT) by 8.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,952 shares of the medical research company's stock after purchasing an additional 1,363 shares during
Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations
GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities
Acquisition supplements CIMAR's cloud-native infrastructure with DeepHealth's AI-powered informatics to deliver connected, efficient and accessible care
RadNet, Inc. ( RDNT ) Q3 2025 Earnings Call November 10, 2025 10:30 AM EST Company Participants Mark Stolper - Executive VP & CFO Howard Berger - Chairman, President & CEO Conference Call Participants David MacDonald - Truist Securities, Inc., Research Division Brian Tanquilut - Jefferies LLC, Research Division John Ransom - Raymond James & Associates, Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division James Sidoti - Sidoti & Company, LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to the RadNet Inc. Third Quarter 2025 Financial Results Conference Call.
While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
LOS ANGELES, Nov. 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global developer of digital health solutions, today reported financial results for its third quarter of 2025.